Product Specification| Host | Human | | Antigen | LAG-3 | | Synonyms | Lymphocyte activation gene 3 protein, CD223, FDC | | Accession | P18627 | | Clone Number | S-SC019 | | Antibody Type | Recombinant mAb | | Isotype | IgG4,k | | Application | Blocking of LAG-3 signaling Functional assays | | Purification | Protein A | | Concentration | 2 mg/ml | | Endotoxin | <1EU/mg | | Conjugation | Unconjugated | | Physical Appearance | Liquid | | Storage Buffer | PBS pH7.4, containing no preservative | | Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution| application | dilution | species | | ELISA | 1.221-5000 ng/ml | |
BackgroundRelatlimab is a Lymphocyte activation gene-3 (LAG-3) inhibitor. It is used in combination with nivolumab to treat melanoma. bio-equip.cn AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
|
中文
